Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 29, 2015 16:03 ET | Source: BioMarin Pharmaceutical Inc.

BioMarin Announces Third Quarter 2015 Financial Results and Company Update

- Vimizim Net Product Revenue $65 million in the Quarter; Vimizim Full-year Revenue Guidance Increased to $220 to $235 million - Full-year Total BioMarin Revenue Guidance Increased to $880 million...